Middle East Blood Plasma Derivative Market Updates : The Bleeding Disorders Dominated the Market

Allied Market Research published a report, titled, "Middle East Blood Plasma Derivatives Market by Type (Albumin, Factor VII, Factor IX Concentrate, Anti-Coagulation Factor, Rh Immunoglobulin, and Others), by Application (Immunodeficiency Diseases, Bleeding Disorders, Liver Conditions, and Others), by End User (Hospitals, Clinics, and Transfusion Centers): Global Opportunity Analysis and Industry Forecast, 2021-2031."

According to the report, the global middle east blood plasma derivatives market generated $1.1 billion in 2021, and is estimated to reach $3.0 billion by 2031, witnessing a CAGR of 9.4% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chains, regional landscapes, and competitive scenarios.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/53998

The expansion of the global Middle East blood plasma derivatives market is propelled by the increased incidence of severe ailments such as immunodeficiency disorders and hemophilia, alongside growing awareness among healthcare professionals regarding the therapeutic applications of blood plasma. However, challenges persist due to the associated side effects of blood plasma derivative therapy and its high treatment costs. Nonetheless, manufacturers' intensified promotional efforts and rising public awareness regarding the significance of blood and plasma donations present promising opportunities in the sector.

In terms of end-users, hospitals dominated the market in 2021, capturing almost three-quarters of the global Middle East blood plasma derivatives market revenue and are poised to maintain their lead through 2031. This segment is also anticipated to exhibit the most rapid Compound Annual Growth Rate (CAGR) of 9.7% during the forecast period, driven by the increasing number of patient visits for blood donation, the rising prevalence of immunodeficiency and bleeding disorders, and a surge in hospitalizations.

By application, the bleeding disorder segment accounted for over one-third of the global Middle East blood plasma derivatives market share in 2021 and is projected to continue its dominance through 2031. Moreover, it is expected to register the fastest CAGR of 9.9% throughout the forecast period, fueled by the rising incidence of bleeding disorders and the expanding utilization of blood plasma derivatives for their treatment in the Middle East region.

𝐒𝐩𝐞𝐚𝐤 𝐭𝐨 𝐎𝐮𝐫 𝐀𝐧𝐚𝐥𝐲𝐬𝐭 @ https://www.alliedmarketresearch.com/connect-to-analyst/A53523

𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬-
Bayer AG
Biotest AG
CSL Limited
Fusion Healthcare Pvt. Ltd.
Grifols, S.A.
Kedrion Biopharma, Inc.
LFB S.A.
Octapharma AG
Sanofi
Takeda Pharmaceutical Co., Ltd.

𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐎𝐟 𝐒𝐭𝐮𝐝𝐲
By type, the others the segment was the highest contributor to the market in 2021.
By application, the bleeding disorders the segment was the highest contributor to the East blood plasma derivative market in 2021.
By end user, the hospitals segment dominated the East blood plasma derivative market in 2021, and is expected to continue this trend during the forecast period.

𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐅𝐨𝐫 𝐒𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬
The study provides an in-depth analysis of the Middle east blood plasma derivative market size and the current trends & future estimations to elucidate imminent investment pockets.
It presents a quantitative analysis of the market from 2022 to 2032 to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the market based on procedures and services assists us to understand the trends in the industry.
Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞- https://www.alliedmarketresearch.com/middle-east-blood-plasma-derivative-market-A53523

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/food-and-beverages
Follow Us on Blog: https://www.dailyreportsworld.com/

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view of providing business insights and consulting to assist its clients in making strategic business decisions and achieving sustainable growth in their respective market domain.

We have professional corporate relations with various companies and this helps us dig out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high-quality of data and help clients in every way possible to achieve success. Each and every piece of data presented in the reports published by us is extracted through primary interviews with top officials from leading companies in domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.